Physician profile
Joe Park
NPI 1083645832
$21,206.35
in general payments reported to CMS, 2019-2025
39 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,189 · 2020: $981 · 2021: $1,058 · 2022: $1,249 · 2023: $1,604 · 2024: $2,644 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,280 · Food and Beverage: $5,311 · Travel and Lodging: $1,101 · Consulting Fee: $1,001 · Education: $35.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,280.00 |
| Food and Beverage | $5,311.13 |
| Travel and Lodging | $1,101.43 |
| Consulting Fee | $1,001.00 |
| Education | $35.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $7,774.69 | 2025 | Vyrsa V1, Vyrsa V1, Senza |
| Boston Scientific Corporation | $3,922.38 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic USA, INC. | $1,930.66 | 2019-2020 | |
| Abbott Laboratories | $1,519.45 | 2019-2024 | Proclaim |
| Medtronic, INC. | $1,186.89 | 2021-2024 | Intellis Adaptivestim |
| Surgentec | $1,001.00 | 2025 | Tilink |
| Spinal Simplicity, LLC | $641.03 | 2021-2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $573.18 | 2019-2023 | Belbuca, Xtampza |
| Nevro Corp. | $505.83 | 2019-2024 | Senza |
| Vertiflex, INC. | $370.33 | 2019 | |
| Forte Bio-Pharma LLC | $222.34 | 2023-2024 | Prolate, Nalocet |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.03 | 2019-2021 | |
| Si-Bone, INC. | $145.62 | 2022-2024 | |
| Vertos Medical, INC. | $117.07 | 2022 | |
| Saluda Medical Americas, INC. | $107.97 | 2024-2025 | Evoke |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.